http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-543187-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6f1cc2d6e8576efbe553f779647a612
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d664bf71ff7a1fc03d685e12038cf2b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-20
filingDate 1940-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1942-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-543187-A
titleOfInvention Processes for producing erythroidine and its salts
abstract 543,187. Erythroidine and its salts. MERCK & CO., Inc., FOLKERS, K., and MAJOR, R. T. July 13, 1940, No. 11674. Addition to 522,225. [Class 2 (iii)] Erythroidine salts are prepared by a process which comprises dissolving a physiologically active alkaloidal fraction in absolute alcohol, acidifying the solution and crystallizing the erythroidine salts from the solution. The starting materials are preferably obtained according to the process of the parent Specification. If desired, the erythroidine salts obtained as above may be decomposed by treatment with alkali to give the pure alkaloid erythroidine. The salts obtained by the process of the present invention are a mixture of stereo-isomers, usually a mixture of two stereoisomerides which have been named α-erythroidine and #-erythroidine, respectively. A series of examples are given, in all of which the starting materials used are those prepared by the process of the parent Specification. The acids which are used in the examples include dry hydrogen chloride, 40 per cent. hydrobromic acid, glacial acetic acid, picrolonic acid, and flavianic acid.
priorityDate 1940-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68369
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449831254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415966609
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415740187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21225539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414866677

Total number of triples: 28.